ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 250 filers reported holding ACADIA PHARMACEUTICALS INC in Q1 2020. The put-call ratio across all filers is 0.73 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,664 | +205.9% | 79,849 | +251.3% | 0.14% | +164.8% |
| Q2 2023 | $544 | -99.9% | 22,730 | -25.3% | 0.05% | -15.6% |
| Q2 2022 | $429,000 | -62.2% | 30,447 | -55.4% | 0.06% | -44.8% |
| Q3 2021 | $1,135,000 | +179.6% | 68,330 | +620.3% | 0.12% | +146.8% |
| Q4 2019 | $406,000 | +6.0% | 9,486 | -10.8% | 0.05% | -9.6% |
| Q3 2019 | $383,000 | +57.6% | 10,638 | -9.2% | 0.05% | +300.0% |
| Q3 2018 | $243,000 | -30.0% | 11,717 | +20.4% | 0.01% | -23.5% |
| Q4 2015 | $347,000 | -69.8% | 9,731 | -72.0% | 0.02% | -69.6% |
| Q3 2015 | $1,148,000 | -34.8% | 34,708 | -17.5% | 0.06% | -17.6% |
| Q2 2015 | $1,762,000 | -22.0% | 42,077 | -39.3% | 0.07% | -24.4% |
| Q1 2015 | $2,258,000 | +532.5% | 69,295 | +516.9% | 0.09% | +260.0% |
| Q4 2014 | $357,000 | -40.7% | 11,233 | -54.6% | 0.02% | -41.9% |
| Q1 2014 | $602,000 | – | 24,751 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baker Brothers Advisors | 27,228,338 | $611,821,000 | 5.19% |
| First Washington CORP | 176,950 | $3,976,000 | 2.06% |
| SECTORAL ASSET MANAGEMENT INC | 783,424 | $17,604,000 | 1.93% |
| HARVEY CAPITAL MANAGEMENT INC | 219,042 | $4,921,000 | 1.84% |
| Ghost Tree Capital, LLC | 400,000 | $8,988,000 | 1.82% |
| Opus Point Partners Management, LLC | 36,733 | $825,000 | 1.62% |
| Palo Alto Investors LP | 1,650,780 | $37,093,000 | 1.59% |
| EMORY UNIVERSITY | 84,714 | $1,904,000 | 1.36% |
| GARRISON BRADFORD & ASSOCIATES INC | 69,000 | $1,550,000 | 1.32% |
| HealthCor Management, L.P. | 1,378,000 | $30,964,000 | 1.05% |